Actinium Pharmaceuticals
ATNM
#9636
Rank
C$55.38 M
Marketcap
$1.78
Share price
0.79%
Change (1 day)
-81.65%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -C$57.8 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -C$72.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 -C$58.43 Million-18.87%
2023 -C$72.03 Million52.24%
2022 -C$47.31 Million36.61%
2021 -C$34.63 Million11.48%
2020 -C$31.07 Million1.46%
2019 -C$30.62 Million-7.37%
2018 -C$33.06 Million-11.46%
2017 -C$37.33 Million10.67%
2016 -C$33.74 Million15.7%
2015 -C$29.16 Million-14.86%
2014 -C$34.25 Million129.19%
2013 -C$14.95 Million-8.55%
2012 -C$16.34 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$51.59 Million-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.75 B-1,386.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$39.89 Million-31.73%๐Ÿ‡บ๐Ÿ‡ธ USA